Journal of the American Academy of Dermatology
Case ReportsNecrobiosis lipoidica diabeticorum treated with chloroquine☆,☆☆
Section snippets
Case report
A 46-year-old white woman, with no personal history of diabetes, but who does have several family members with type II diabetes mellitus, had a 6-year history of a persistently tender plaque on the anterior aspect of her left lower leg. This location had been the site of trauma on 2 prior occasions. She was given oral pentoxifylline 400 mg three times daily for 1 month, but she stopped treatment because of gastrointestinal distress. Subsequent therapy included a 2-month trial of clobestasol
Discussion
Although various pharmacologic agents have been used in the treatment of NLD, we could find no previous reports of the use of antimalarials in the treatment of classic NLD.
Attempted treatments have been directed at some of the presumptive underlying mechanisms of NLD: inflammatory, microangiopathic, and structural disease. Intralesional and topical corticosteroids are frequently used in the treatment of NLD.1, 3 Systemic corticosteroid treatment has also been reported in the literature to be
References (27)
- et al.
Necrobiosis lipoidica
J Am Acad Dermatol
(1991) Antimalarial medications in dermatology: a review
Dermatol Clin
(1991)- et al.
Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas
J Am Acad Dermatol
(1990) - et al.
Antimalarials for control of disseminated granuloma annulare in children
J Am Acad Dermatol
(1994) Antimalarials
J Am Acad Dermatol
(1981)- et al.
Chloroquine, quinine, procaine, quinidine, tricyclic antidepressants, and methylxanthines as prostaglandin agonists and antagonists
Lancet
(1976) - et al.
Granulomatous reactions
Noninfectious granulomas
Cutaneous manifestations of endocrine diseases
- et al.
A case of necrobiosis lipoidica treated with systemic corticosteroid
J Dermatol
(1993)
Adverse effects of corticosteroids
Adverse Drug React Toxicol Rev
Drug-induced disorders of glucose tolerance
Ann Intern Med
High dose nicotinamide in the treatment of necrobiosis lipoidica
Br J Dermatol
Cited by (0)
- ☆
This supplement is made possible through an unrestricted educational grant from Stiefel Laboratories to the American Academy of Dermatology.
- ☆☆
Reprint requests: Jerome Shupack, MD, New York University School of Medicine, Department of Dermatology, Dermatopharmacology Unit, 560 First Ave, H-158, New York, NY 10016.